Adding self-administered music listening to sleep hygiene education for insomnia in young men during subacute high-altitude acclimatization (4100 m): a preliminary comparative study with retrospective data

Insomnia is highly prevalent at high altitude, primarily driven by hypoxia-induced psychophysiological hyperarousal. Although cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment, its implementation is often restricted in resource-limited high-altitude settings. Music listening has shown promise for sleep improvement in lowland populations, but its additive value in mitigating hypoxia-related sleep disturbances remains unexplored. To evaluate the feasibility and preliminary associations of adding self-administered music listening intervention (SMLI)—a scalable intervention requiring only a personal audio device and headphones, no specialist supervision—to sleep hygiene education (SHE) compared with SHE alone for insomnia and co-occurring anxiety in young men residing at 4100 m, using robust statistical adjustments for non-randomized data. This retrospective comparative study analyzed de-identified data from 35 males (aged 20–45 years) diagnosed with insomnia disorder. The sample size was determined by the availability of eligible participants from the original wellness program, consistent with the hypothesis-generating objective of this exploratory study to generate effect size estimates for future randomized controlled trials (RCTs). Key inclusion criteria included high-altitude residence duration of 1–3 months and no use of hypnotic medications. Participants were categorized into SMLI + SHE ( n = 18) or SHE-only ( n = 17) groups based on actual program participation. The intervention consisted of daily SMLI sessions lasting 30 min over 4 weeks (requiring only a personal audio device and headphones, with no specialist guidance). Adherence was monitored, with ≥ 80% compliance considered adequate; a per-protocol (PP) analysis was conducted, including only participants who met this adherence threshold. To mitigate selection bias and baseline imbalances, the primary analysis employed analysis of covariance (ANCOVA) adjusted for baseline scores, supplemented by sensitivity analyses. Given the exploratory nature and small sample size, we prioritized effect sizes (Cohen’s d, ηp 2 ) and 95% confidence intervals (CIs) alongside p -values. Primary outcomes were changes in the modified Pittsburgh Sleep Quality Index (PSQI, excluding the medication component, maximum score = 18) and the Insomnia Severity Index (ISI); the secondary outcome was the Self-Rating Anxiety Scale (SAS). Of 87 screened individuals, 35 males met the eligibility criteria and were included in the analysis. Baseline demographic characteristics (age, BMI, and education level) were comparable between groups (all p > 0.05); however, the SHE-only group had slightly higher baseline PSQI scores (mean ± SD: SMLI + SHE 10.33 ± 1.98 vs. SHE-only 11.24 ± 2.15; SMD = 0.44). ANCOVA revealed that the SMLI + SHE group was associated with significantly better post-intervention sleep quality than the SHE group (adjusted mean modified PSQI: 5.91 [95% CI: 5.32–6.50] vs. 6.98 [95% CI: 6.37–7.59]; F (1, 32) = 6.84, p = 0.013; Cohen’s d = 0.82 [95% CI: 0.27–1.35]; ηp 2 = 0.176). Similarly, insomnia severity (ISI) was associated with greater reduction in the SMLI + SHE group (adjusted mean: 4.85 [95% CI: 3.98–5.72] vs. 7.04 [95% CI: 6.15–7.93]; F (1, 32) = 5.38, p = 0.027; Cohen’s d = 0.76 [95% CI: 0.21–1.29]; ηp 2 = 0.144). For anxiety, the reduction in SAS scores did not differ significantly between groups (SMLI + SHE: from 53.28 to 47.39, mean reduction = 5.89; SHE-only: from 52.76 to 48.06, mean reduction = 4.70; adjusted between-group difference: p = 0.186). The SMLI + SHE group showed a moderate effect size (Cohen’s d = 0.45 [95% CI: -0.09 to 0.98]). All 18 participants in the SMLI + SHE group met the ≥ 80% adherence threshold (mean adherence rate: 94.2% ± 4.1%), suggesting the feasibility of the self-administered protocol in this resource-limited setting; however, this high adherence may reflect selection bias, as participants who opted for SMLI may have been more motivated. No adverse events (e.g., auditory discomfort or exacerbated anxiety) were reported throughout the 4-week intervention period. In this resource-limited, high-altitude setting, adjunctive SMLI combined with SHE was associated with clinically meaningful improvements in sleep quality and insomnia severity compared with SHE alone. No statistically significant benefit was observed for anxiety symptoms in this preliminary sample. Given the retrospective non-randomized design, small sample size, reliance on subjective outcomes, and absence of objective sleep measures—particularly polysomnography to distinguish subjective sleep perception from underlying high-altitude periodic breathing and nocturnal hypoxemia—these findings are hypothesis-generating and associative, precluding definitive causal inference. However, the favorable safety profile, promising feasibility, and moderate-to-large effect sizes (Cohen’s d = 0.76–0.82) provide foundational data to inform the design of future adequately powered RCTs specifically targeting SMLI in this high-altitude population.

Authors

Institutions

Publication Details

Journal
BMC Complementary Medicine and Therapies
Published
2026-11-17
DOI
https://doi.org/10.1186/s12906-026-05603-z
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Adding self-administered music listening to sleep hygiene education for insomnia in young men during subacute high-altitude acclimatization (4100 m): a preliminary comparative study with retrospective data

Rizhao Pang, Zhaobing Tang, Jian Liu, Ying He et al.
1 links
BMC Complementary Medicine and Therapies
Sleep and related disorders
article

Adding self-administered music listening to sleep hygiene education for insomnia in young men during subacute high-altitude acclimatization (4100 m): a preliminary comparative study with retrospective data

Rizhao Pang, Zhaobing Tang, Jian Liu, Ying He, Chao Dong, Li Zheng, Xingang Bai, Yalin Lei, Zesha Ling, Jinqi Zheng, Fungxu Que
article en

Abstract

Insomnia is highly prevalent at high altitude, primarily driven by hypoxia-induced psychophysiological hyperarousal. Although cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment, its implementation is often restricted in resource-limited high-altitude settings. Music listening has shown promise for sleep improvement in lowland populations, but its additive value in mitigating hypoxia-related sleep disturbances remains unexplored. To evaluate the feasibility and preliminary associations of adding self-administered music listening intervention (SMLI)—a scalable intervention requiring only a personal audio device and headphones, no specialist supervision—to sleep hygiene education (SHE) compared with SHE alone for insomnia and co-occurring anxiety in young men residing at 4100 m, using robust statistical adjustments for non-randomized data. This retrospective comparative study analyzed de-identified data from 35 males (aged 20–45 years) diagnosed with insomnia disorder. The sample size was determined by the availability of eligible participants from the original wellness program, consistent with the hypothesis-generating objective of this exploratory study to generate effect size estimates for future randomized controlled trials (RCTs). Key inclusion criteria included high-altitude residence duration of 1–3 months and no use of hypnotic medications. Participants were categorized into SMLI + SHE ( n = 18) or SHE-only ( n = 17) groups based on actual program participation. The intervention consisted of daily SMLI sessions lasting 30 min over 4 weeks (requiring only a personal audio device and headphones, with no specialist guidance). Adherence was monitored, with ≥ 80% compliance considered adequate; a per-protocol (PP) analysis was conducted, including only participants who met this adherence threshold. To mitigate selection bias and baseline imbalances, the primary analysis employed analysis of covariance (ANCOVA) adjusted for baseline scores, supplemented by sensitivity analyses. Given the exploratory nature and small sample size, we prioritized effect sizes (Cohen’s d, ηp 2 ) and 95% confidence intervals (CIs) alongside p -values. Primary outcomes were changes in the modified Pittsburgh Sleep Quality Index (PSQI, excluding the medication component, maximum score = 18) and the Insomnia Severity Index (ISI); the secondary outcome was the Self-Rating Anxiety Scale (SAS). Of 87 screened individuals, 35 males met the eligibility criteria and were included in the analysis. Baseline demographic characteristics (age, BMI, and education level) were comparable between groups (all p > 0.05); however, the SHE-only group had slightly higher baseline PSQI scores (mean ± SD: SMLI + SHE 10.33 ± 1.98 vs. SHE-only 11.24 ± 2.15; SMD = 0.44). ANCOVA revealed that the SMLI + SHE group was associated with significantly better post-intervention sleep quality than the SHE group (adjusted mean modified PSQI: 5.91 [95% CI: 5.32–6.50] vs. 6.98 [95% CI: 6.37–7.59]; F (1, 32) = 6.84, p = 0.013; Cohen’s d = 0.82 [95% CI: 0.27–1.35]; ηp 2 = 0.176). Similarly, insomnia severity (ISI) was associated with greater reduction in the SMLI + SHE group (adjusted mean: 4.85 [95% CI: 3.98–5.72] vs. 7.04 [95% CI: 6.15–7.93]; F (1, 32) = 5.38, p = 0.027; Cohen’s d = 0.76 [95% CI: 0.21–1.29]; ηp 2 = 0.144). For anxiety, the reduction in SAS scores did not differ significantly between groups (SMLI + SHE: from 53.28 to 47.39, mean reduction = 5.89; SHE-only: from 52.76 to 48.06, mean reduction = 4.70; adjusted between-group difference: p = 0.186). The SMLI + SHE group showed a moderate effect size (Cohen’s d = 0.45 [95% CI: -0.09 to 0.98]). All 18 participants in the SMLI + SHE group met the ≥ 80% adherence threshold (mean adherence rate: 94.2% ± 4.1%), suggesting the feasibility of the self-administered protocol in this resource-limited setting; however, this high adherence may reflect selection bias, as participants who opted for SMLI may have been more motivated. No adverse events (e.g., auditory discomfort or exacerbated anxiety) were reported throughout the 4-week intervention period. In this resource-limited, high-altitude setting, adjunctive SMLI combined with SHE was associated with clinically meaningful improvements in sleep quality and insomnia severity compared with SHE alone. No statistically significant benefit was observed for anxiety symptoms in this preliminary sample. Given the retrospective non-randomized design, small sample size, reliance on subjective outcomes, and absence of objective sleep measures—particularly polysomnography to distinguish subjective sleep perception from underlying high-altitude periodic breathing and nocturnal hypoxemia—these findings are hypothesis-generating and associative, precluding definitive causal inference. However, the favorable safety profile, promising feasibility, and moderate-to-large effect sizes (Cohen’s d = 0.76–0.82) provide foundational data to inform the design of future adequately powered RCTs specifically targeting SMLI in this high-altitude population.

BMC Complementary Medicine and Therapies
Chengdu Military General Hospital (CN)
Good health and well-being
Sleep and related disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon